Profiel
F.
Allan Gordon worked as the Chief Executive Officer at Nile Therapeutics, Inc. and as the Medical Director-Scandinavia at Bristol Myers Squibb Co. He also held the position of Senior Director-Clinical Research at Scios, Inc. and Vice President-Clinical at XOMA Corp.
He was the Senior Vice President-Clinical Development at Resverlogix Corp.
for six years.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Dr. Gordon earned a doctorate degree from Karolinska Institutet.
Eerdere bekende functies van F. Allan Gordon
| Bedrijven | Functie | Einde |
|---|---|---|
| XOMA CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-08-2017 |
| RESVERLOGIX CORP. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
Opleiding van F. Allan Gordon
| Karolinska Institutet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| XOMA CORPORATION | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Nile Therapeutics, Inc. /Old/ | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
